MARKET

GLTO

GLTO

Galecto Inc.
NASDAQ
27.31
+5.51
+25.28%
Opening 12:00 02/12 EST
OPEN
21.89
PREV CLOSE
21.80
HIGH
27.80
LOW
21.89
VOLUME
280.52K
TURNOVER
--
52 WEEK HIGH
38.33
52 WEEK LOW
2.010
MARKET CAP
43.56M
P/E (TTM)
-2.2748
1D
5D
1M
3M
1Y
5Y
1D
Galecto Prices Upsized Public Offering to Fund DMR-001
TipRanks · 19h ago
Galecto Announces Offering Of 14,473,685 Shares Of Common Stock
Benzinga · 19h ago
GALECTO INC - OFFERING 14,473,685 SHARES OF COMMON STOCK - SEC FILING
Reuters · 19h ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 20h ago
BUZZ-U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac
Reuters · 23h ago
BUZZ-U.S. STOCKS ON THE MOVE-Klaviyo, Frontier Group, Wabtec
Reuters · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Shopify, GlobalFoundries, Constellation Energy
Reuters · 1d ago
BUZZ-Biopharma co Galecto drops after $275 mln stock sale
Reuters · 1d ago
More
About GLTO
Galecto, Inc. is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company’s pipeline consists of small molecule drug candidates that target cancer and fibrosis signaling pathways, including a preclinical dual inhibitor of ENL-YEATS and FLT3 (GB3226) for multiple genetic subsets of AML; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications and (an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis. It is developing GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 for multiple molecularly defined subsets of acute myeloid leukemia (AML). The Company’s pipeline is GB1211, its oral small molecule galectin-3 inhibitor candidate, which is in development for the treatment of non-small cell lung cancer (NSCLC), melanoma, head and neck squamous cell carcinoma (HNSCC), and decompensated cirrhosis.

Webull offers Galecto Inc stock information, including NASDAQ: GLTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLTO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLTO stock methods without spending real money on the virtual paper trading platform.